Adam C. Mirando

839 total citations
23 papers, 636 citations indexed

About

Adam C. Mirando is a scholar working on Molecular Biology, Ophthalmology and Immunology and Allergy. According to data from OpenAlex, Adam C. Mirando has authored 23 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Ophthalmology and 4 papers in Immunology and Allergy. Recurrent topics in Adam C. Mirando's work include RNA and protein synthesis mechanisms (7 papers), Retinal Diseases and Treatments (5 papers) and RNA modifications and cancer (5 papers). Adam C. Mirando is often cited by papers focused on RNA and protein synthesis mechanisms (7 papers), Retinal Diseases and Treatments (5 papers) and RNA modifications and cancer (5 papers). Adam C. Mirando collaborates with scholars based in United States, South Korea and Spain. Adam C. Mirando's co-authors include Aleksander S. Popel, Christopher S. Francklyn, Jordan J. Green, Karen M. Lounsbury, Jayoung Kim, Barrie Wilkinson, Niranjan B. Pandey, Raquel Lima e Silva, Peter A. Campochiaro and Min Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Biochemistry.

In The Last Decade

Adam C. Mirando

22 papers receiving 621 citations

Peers

Adam C. Mirando
Comparison fields: 5 of 92
  • Molecular Biology 415
  • Ophthalmology 96
  • Immunology 70
  • Biomedical Engineering 64
  • Biomaterials 62
Liujiang Song United States
Harris E. McFerrin United States
Francesca Piaggio Italy
Tadashi Shimo‐Oka Japan
Yuchen Jiang China
Jérôme Mauris United States
Ashley M. Woodward United States
Claudia Schöllmann Germany
Neung‐Seon Seo United States
Donna M. Small United Kingdom
Liujiang Song United States View profile →
Citations per field, relative to Adam C. Mirando
Adam C. Mirando · 1×
Citations per year, relative to Adam C. Mirando
Adam C. Mirando · 1×

Countries citing papers authored by Adam C. Mirando

Since Specialization
Citations

This map shows the geographic impact of Adam C. Mirando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam C. Mirando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam C. Mirando more than expected).

Fields of papers citing papers by Adam C. Mirando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam C. Mirando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam C. Mirando. The network helps show where Adam C. Mirando may publish in the future.

Co-authorship network of co-authors of Adam C. Mirando

This figure shows the co-authorship network connecting the top 25 collaborators of Adam C. Mirando. A scholar is included among the top collaborators of Adam C. Mirando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam C. Mirando. Adam C. Mirando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth Cell Death Discovery Wendy Yang, Alex Chao et al. 2
2 Gel-forming therapeutic peptide exhibits sustained delivery and efficacy in a mouse model of triple-negative breast cancer Peptides Adam C. Mirando, Ioanna Liatsou et al. 1
3 Anti-angiogenic collagen IV-derived peptide target engagement with αvβ3 and α5β1 in ocular neovascularization models iScience Raquel Lima e Silva, Adam C. Mirando et al. 7
4 The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye International Journal of Retina and Vitreous Quan Dong Nguyen, Jeffrey S. Heier et al. 39
5 Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling International Journal of Molecular Sciences Adam C. Mirando, Raquel Lima e Silva et al. 16
6 A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology PLoS Computational Biology Chen Zhao, Adam C. Mirando et al. 43
7 Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization Acta Biomaterialia Jayoung Kim, Raquel Lima e Silva et al. 17
8 Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma npj Systems Biology and Applications Mohammad Jafarnejad, Richard J. Sové et al. 21
9 A collagen IV–derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling JCI Insight Adam C. Mirando, Jikui Shen et al. 39
10 Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple‐negative breast cancer cells Journal of Biomedical Materials Research Part A Jayoung Kim, Ron B. Shmueli et al. 38
11 Tyrosine kinase blocking collagen IV–derived peptide suppresses ocular neovascularization and vascular leakage Science Translational Medicine Raquel Lima e Silva, Yogita Kanan et al. 45
12 Assessing the effects of threonyl-tRNA synthetase on angiogenesis-related responses Methods Adam C. Mirando, Karen M. Lounsbury et al. 5
13 Gene delivery nanoparticles to modulate angiogenesis Advanced Drug Delivery Reviews Jayoung Kim, Adam C. Mirando et al. 61
14 Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor Scientific Reports Adam C. Mirando, Pengfei Fang et al. 22
15 Characterization Of A Non-Canonical Function For Threonyl-Trna Synthetase In Angiogenesis ScholarWorks -A service of University of Vermont Libraries (University of Vermont) Adam C. Mirando 1
16 Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase Nature Communications Pengfei Fang, Xue Yu et al. 69
17 Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo Proceedings of the National Academy of Sciences Eva Maria Novoa, Noelia Camacho et al. 61
18 Secreted Threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis Scientific Reports Adam C. Mirando, Barrie Wilkinson et al. 70
19 Substrate Specificity and Catalysis by the Editing Active Site of Alanyl-tRNA Synthetase from Escherichia coli Biochemistry Zvi Pasman, Susan M. Robey-Bond et al. 25
20 Exposure to flame retardants promotes increased consumption of simple sugars The FASEB Journal Stephen R. Hennigar, Adam C. Mirando et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026